Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduning granules for influenza (wind-heat pattern)
CTR20240159Phase 3Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Reduning granules with Placebo (Reduning granules simulant) (2 arms). Primary endpoints: Adverse events and adverse drug reactions and Time to relief of influenza symptoms. Started Jan 2024; status: completed.
02
Drugs
Reduning Granules
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20240159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240159.